Galvanize Therapeutics

Galvanize Therapeutics, Inc. is a Redwood City, California medical device company founded in 2015 by Jonathan Waldstreicher, MD and William Krimsky, MD, and created and incubated by Apple Tree Partners (ATP). Galvanize develops pulsed electric field (PEF) therapies that deliver high-voltage, short-duration energy locally to alter the transmembrane potential of targeted cells, inducing non-thermal regulated cell death without denaturing cellular proteins or the extracellular matrix. Its Aliya PEF System is cleared for surgical ablation of soft tissue and is being studied in non-small cell lung cancer, while RheOx addresses chronic bronchitis in the airway. The company received FDA 510(k) clearance for the Aliya EX Generator in May 2026. Galvanize is a privately held, clinically-focused device manufacturer and publishes no public developer program, API, SDK, or machine-readable interface.

Galvanize Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Health Care, Oncology, and Pulmonology.

Galvanize Therapeutics’ developer surface includes engineering blog, support, and 11 more developer resources.

🌐 Visit website 📡 Source on GitHub

12.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyMedical DevicesHealth CareOncologyPulmonologyMedical TechnologyLife SciencesAblation

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 12.2/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 1.1 / 17

Commercial Clarity 3.6 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.9 / 9

Regulatory Posture 2.6 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/galvanize-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 7

The organization behind the API

Website

About

Blog

BlogRSS

Careers

LinkedIn

Investors

Investors

Scroll for all 7

Other 1

Properties that don't map to a standard resource type

Products

Products

Source (apis.yml)

aid: galvanize-therapeutics
name: Galvanize Therapeutics
description: Galvanize Therapeutics, Inc. is a Redwood City, California medical device company founded in 2015 by Jonathan
  Waldstreicher, MD and William Krimsky, MD, and created and incubated by Apple Tree Partners (ATP). Galvanize develops pulsed
  electric field (PEF) therapies that deliver high-voltage, short-duration energy locally to alter the transmembrane potential
  of targeted cells, inducing non-thermal regulated cell death without denaturing cellular proteins or the extracellular matrix.
  Its Aliya PEF System is cleared for surgical ablation of soft tissue and is being studied in non-small cell lung cancer,
  while RheOx addresses chronic bronchitis in the airway. The company received FDA 510(k) clearance for the Aliya EX Generator
  in May 2026. Galvanize is a privately held, clinically-focused device manufacturer and publishes no public developer program,
  API, SDK, or machine-readable interface.
url: https://raw.githubusercontent.com/api-evangelist/galvanize-therapeutics/refs/heads/main/apis.yml
image: https://galvanizetx.com/wp-content/uploads/Galvanize-G-Favicon.svg
x-type: company
x-source: harvest:secondary-market
x-tier: profile
x-tier-reason: enriched
specificationVersion: '0.20'
created: '2026-08-04'
modified: '2026-08-04'
tags:
- Company
- Medical Devices
- Health Care
- Oncology
- Pulmonology
- Medical Technology
- Life Sciences
- Ablation
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/galvanize-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/galvanize-therapeutics-llms.txt
- type: Website
  url: https://galvanizetx.com/
- type: About
  url: https://galvanizetx.com/about/
- type: Blog
  url: https://galvanizetx.com/news/
- type: BlogRSS
  url: https://galvanizetx.com/feed/
- type: Support
  url: https://galvanizetx.com/contact-us/
- type: TermsOfService
  url: https://galvanizetx.com/terms-of-use/
- type: PrivacyPolicy
  url: https://galvanizetx.com/privacy-policy/
- type: Careers
  url: https://galvanizetx.com/careers/
- type: LinkedIn
  url: https://www.linkedin.com/company/galvanize-therapeutics
- type: Products
  url: https://galvanizetx.com/products-pipeline/
- type: Investors
  url: https://forgeglobal.com/galvanize-therapeutics_stock/
x-enrichment:
  date: '2026-08-04'
  status: minimal
  artifacts_added: 2
  pass: local-v1